Indication:
Nomi® Nasal Spray: Acute treatment of migraine in adults and pediatric patients (12-17 years age).
Dosage & Administration:
The initial recommended dose is 2.5 mg. If symptoms persist or return within 24 hours, a second dose has been shown to be effective but should not be taken within 2 hours of the initial dose.
Preparation:
Nomi® Nasal Spray: Each bottle contains solution adequate for 14 metered doses.
